🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔷 ¡Lanzamiento! 📘 II Clínicas Interamericanas de Cardiología #Cardiogeriatría: de la prevención al tratamiento +83 autores | +15 países | Respaldado por SIAC Una obra para transformar la atención cardiovascular de las personas mayores. 📍Estreno:SIAC Cartagena 🇨🇴

Florian Kronenberg, Magda Daccord, et al made this important & influential document fly: "The Brussels International Declaration on Lipoprotein(a) Testing and Management". Patients, politicians, clinicians & sceintists: MEASURE Lp(A) IN ALL! atherosclerosis-journal.com/article/S0021-… Open access

Maxima Mendez MD. FSIAC,FACC. SIAC Thanks Max for being my friend and guide my path with your example! I have so many mentors in this journey and you are one of them! Thanks to all my professors!

At the #LXIVCongress of the Sociedad Ecuatoriana de Cardiología, we discussed key topics on #lipidology and #atherosclerosis: 1️⃣ Familial Hypercholesterolemia - 2️⃣ Lp(a): What’s New? 3️⃣ Combined LLT Treatment 4️⃣ Residual Risk Beyond LDL-c Great for experience.

It’s an honor to support this vital initiative in Ecuador, led by the Pichincha Cardiology Nucleus. Our sincere congrats to the entire team, under the leadership of Dr. Liliana Cárdenas. Thanks for the opportunity to be part of such meaningful work. #FamiliarHipercolesterolemia

🎓 ¡Ellos son los Fellows SIAC 2025! Reconocidos por su excelencia en cardiología y su compromiso con el avance de la medicina cardiovascular. 👩‍⚕️👨‍⚕️ ¿Y tú, qué esperás para ser parte? Si tenés más de 10 años de experiencia y querés unirte a este grupo de referentes, ¡postúlate y

We announced today that Verve has entered into a definitive agreement to be acquired by Eli Lilly and Company. Lilly shares our determination and dedication to transform the treatment paradigm for the millions of patients worldwide living with cardiovascular disease, and we

📍IAS will be at the 30th Dominican Congress of Cardiology 2025, hosted by @SODOCARDIO, at the Hard Rock Hotel Convention Center in Punta Cana! 🇩🇴 ✨ Don’t miss the first-ever IAS/SODOCARDIO joint session on lipids in Dominican Republic! International Atherosclerosis Society (IAS) bit.ly/45ZH2C9

Thank you to Dra Máxima Mendez, Rodrigo Alonso Karlezi (Rodrigo Alonso Karlezi), Alberto J. Lorenzatti, MD, MTFAC, FACC, and Vivencio Barrios for their extraordinary presentations about the management of atherosclerosis. It's wonderful to see so many of IAS' experts involved in the

We’re pleased to bring lipid update discussions together with different Cardiology Societies across the region. Thanks for the support of the International Atherosclerosis Society (IAS) (IAS) along the road.

La Sociedad Internacional de Aterosclerosis (IAS) estuvo presente en el XXX Congreso de la Sociedad Dominicana de Cardiología en #puntacana. Gracias Michelle M D Winokur y Rodrigo Alonso por venir y difundir la misión y visión IAS a nuestros colegas en la República Dominicana.

🚨 Are you ready? The biggest event in cardiovascular prevention in the Americas is coming! 🌎❤️ SIAC PREVENT CONGRESS 2025 – Mendoza, Argentina 🇦🇷 Inspiration, innovation & impact await. Don’t miss it! SIAC Adrian Baranchuk MD FACC FRCPC FCCS FSIAC Gonzalo Perez #SIACPrevent2025 #CardioPrevention

Proud to lead the authorship of the chapter on dyslipidemia and cardiovascular disease in this major update of the SIAC textbook. A pleasure to collaborate with Dr. Alberto Lorenzati, a renowned authority in lipidology. Grateful to the editorial team for the opportunity. #Lipid

Collaborating with great minds today at the EAS LATAM Meeting 🇪🇺🌎 We're working on meaningful steps to improve cardiovascular atherosclerotic disease across Latin America. Proud to be part of the conversations shaping real change. European Atherosclerosis Society #LATAMScience

Apply today to be in the first cohort of the IAS Inflammation Academy. The year-long program will begin with a one-day session in Madrid, Spain on August 28. Travel stipend available for most attendees. Learn more and apply NOW: bit.ly/4e5Os9b

SURMOUNT-5 (NEJM 2025): Tirzepatide vs Semaglutide in Obesity Tirzepatide led to: ✅ −20.2% body weight (~−22.8 kg) ✅ −18.4 cm waist ✅ 64.6% ≥15% weight loss (vs 40.1%) ✅ 31.6% ≥25% loss (vs 16.4%) 🔥 Outperformed semaglutide in all endpoints. nej.md/44ZeMPz

‼️📹#TGThursdays📹‼️ The third and final session in IAS' #Hypertriglyceridemia and #ASCVD Risk video series is presented by Viviane Z. Rocha, MD (Viviane Zorzanelli Rocha). In the video, Dr. Rocha talks about the therapeutic options for hypertriglyceridemia. Watch to learn more:

3/3 💡Lección La edad no es contraindicación. 💪Si el paciente es funcional, con riesgo CV elevado y sin contraindicaciones…el beneficio está. Agregar los 9 esenciales. 🔍 No tratar años. Tratar personas. Maxima Mendez MD. FSIAC,FACC. #PCSK9 #Lípidos #Cardiogeriatría #PrevenciónCv